| Bioactivity | HBV-IN-12 is a potent hepatitis B surface antigen (HBsAg) inhibitor (0.001 μM< EC50 ≤0.05 μM). HBV-IN-12 shows anti-HBV DNA activity (0.001 μM＜EC50 ≤0.02 μM). From patent WO2021204252A1, compound 15[1]. |
| Name | HBV-IN-12 |
| CAS | 2724229-06-3 |
| Formula | C23H27NO8 |
| Molar Mass | 445.46 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Tetracyclic compound as hepatitis b surface antigen inhibitor. WO2021204252A1. |
HBV-IN-12
CAS: 2724229-06-3 F: C23H27NO8 W: 445.46
HBV-IN-12 is a potent hepatitis B surface antigen (HBsAg) inhibitor (0.001 μM< EC50 ≤0.05 μM). HBV-IN-12 shows anti-H
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.